miR-495 inhibited the expression of its target gene Fto, resulting in the promotion of the transformation of macrophages into M1-type pro-inflammatory macrophages, and aggravated insulin resistance and adipose tissue inflammation in type 2 diabetes mellitus (T2D) -mice (Hu et al., 2019a). The gene discussed is FTO; the disease is type 2 diabetes mellitus.